Tumors are made up of many types of cells, both cancerous and benign. The specific complexity of the cells inside brain tumors has been a trademark of the disease, one that makes treatment extremely difficult. While scientists ...
Jun 28, 2022
0
121
When a non-metastatic brain tumor—a meningioma—recurs after surgery and radiation treatment, a patient is out of options. No drugs are approved for these aggressive tumors, which occur in up to 20% of cases and can lead ...
May 9, 2022
0
615
In a recent study published in Nature Biomedical Engineering, a team led by researchers at Massachusetts General Hospital (MGH) has demonstrated that magnetic resonance imaging (MRI) and artificial intelligence (AI) can be ...
Dec 1, 2021
0
83
Glioblastomas are aggressive brain tumors that are commonly diagnosed through a risky and invasive surgical biopsy. A team of researchers led by Hong Chen at Washington University in St. Louis has developed a noninvasive ...
Nov 12, 2021
0
11
For many cancers, doctors are increasingly looking to the DNA that solid tumors shed into the blood stream to help with diagnosis and monitoring. But brain cancer has been a different story thanks to the natural blockade ...
Oct 21, 2020
0
16
By applying unsupervised and automated machine learning techniques to the analysis of millions of cancer cells, Rebecca Ihrie and Jonathan Irish, both associate professors of cell and developmental biology, have identified ...
Jun 25, 2020
0
4
Eight years ago, Kaitlyn Dorman was so sick with cancer she was paralyzed and her vision blurred. Dependent on a wheelchair, the little girl was confined to living on the first floor of her family's home.
Feb 18, 2019
0
5
Around a glioblastoma, a very aggressive brain tumor, cells of the human immune system help the tumor instead of attacking it. To explore the interaction of these cells, scientists of the University of Twente have created ...
Feb 8, 2019
0
2
A biomedical tool that tricks aggressive brain tumors such as glioblastoma into migrating into an external container rather than throughout the brain has been designated a "Breakthrough Device" by the U.S. Food and Drug Administration ...
Feb 6, 2019
0
6474
A new study by KAIST researchers identified where the mutation causing glioblastoma starts. According to the study, neural stem cells away from the tumor mass are the cells of origin that contain mutation drivers for glioblastoma, ...
Aug 2, 2018
0
143
